During the past decade, Grandview Medical Center - Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Grandview Medical Center - Cancer Center" are "Brain Metastases From Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Pancreas Adenocarcinoma" (1 trials). Many other conditions were trialed in "Grandview Medical Center - Cancer Center" in a lesser frequency.

Most popular intervention types in "Grandview Medical Center - Cancer Center" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Best Standard of Care" (1 trials), "Gemcitabine" (1 trials), "NovoTTF-200M device" (1 trials), "NovoTTF-200T" (1 trials) and "nab paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grandview Medical Center - Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Grandview Medical Center - Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Grandview Medical Center - Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grandview Medical Center - Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".